AU2002254631A1 - Enantiomers of n-((2'-(((4,5-dimethyl-3-isoxazolyl) amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-n,3,3-trimethylbutanamide - Google Patents

Enantiomers of n-((2'-(((4,5-dimethyl-3-isoxazolyl) amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-n,3,3-trimethylbutanamide

Info

Publication number
AU2002254631A1
AU2002254631A1 AU2002254631A AU2002254631A AU2002254631A1 AU 2002254631 A1 AU2002254631 A1 AU 2002254631A1 AU 2002254631 A AU2002254631 A AU 2002254631A AU 2002254631 A AU2002254631 A AU 2002254631A AU 2002254631 A1 AU2002254631 A1 AU 2002254631A1
Authority
AU
Australia
Prior art keywords
trimethylbutanamide
isoxazolyl
oxazolyl
enantiomers
sulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254631A
Inventor
David E. Hughes
Beth C. Seidenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002254631A1 publication Critical patent/AU2002254631A1/en
Abandoned legal-status Critical Current

Links

AU2002254631A 2001-04-16 2002-04-12 Enantiomers of n-((2'-(((4,5-dimethyl-3-isoxazolyl) amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-n,3,3-trimethylbutanamide Abandoned AU2002254631A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/284,080 2001-04-16

Publications (1)

Publication Number Publication Date
AU2002254631A1 true AU2002254631A1 (en) 2002-10-28

Family

ID=

Similar Documents

Publication Publication Date Title
ATE254115T1 (en) ENDOTHELINE ANTAGONISTS: N- 2'- (4,5-DIMETHYL-3- ISOXAZOLYL) AMINO)SULFONYL)-4-(2-OXAZOLYL) 1,1'- BIPHENYL)-2-YL)METHYL) -N,3,3 -TRIMETHYLBUTANAMIDE AND N-(4,5-DIMETHYL-3-ISOXAZOLYL) -2'- (3,3- DIMETHYL-2-OXO-1-PYRROLIDINYL) METHYL) -4'-(2-OXAZOLYL) 1,1' -BIPHENYL)-2-SULFONAMIDE AND SALTS THEREOF
HK1090294A1 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4- oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate ;
HK1071373A1 (en) Novel polymorph of n-methyl-n-(3-3-2-thienylcarbonyl-pyrazol- 1,5-aplha-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
HK1059931A1 (en) Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substitued aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
BR0214263B1 (en) processes for the preparation of a hair care composition.
NO20033566D0 (en) Acylated 6,7,8,9-tetrehydro-5H-benzocycloheptenylamines and their use as pharmaceutical agents
BR0307060A (en) n- (phenyl-4-substituted) -anthanilic acid hydroxamate esters
IL209789A0 (en) Metabolites of 3-(2-dimethylaminomethyl-cyclohexyl)- phenol, pharmaceutical compositions comprising the same and uses thereof
IS2473B (en) Composition containing N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4- (1,3,4-oxadiazol-2-yl) phenyl) pyridine-3-sulfonamide (ZD4054), or pharmaceutically its recognized salt, and EGFR TKI, or its pharmaceutically acceptable salt
EE05385B1 (en) Broad-spectrum Á2- (Substituted Áamino) Benzothiazole Sulphonamides ÁkuiÁHIVÁProtease Inhibitors, Methods of Preparation, and UseUnited Pharmaceutical Formulations
AU2001250892A1 (en) Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
AU2003301857A1 (en) New process for the preparation of racemic ((2s(2r*(r(r*)))) and ((2r(2s*(s(s*))))-(plus or minus)- alpha,alpha' -(imino-bis(methylene))bis(6-fluoro-chroman-2-methanol) and its pure (2s(2r*(r(r*)and
HUP0401694A3 (en) Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use
AU2002326432A1 (en) Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
AU2003223637A1 (en) Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl) -n-pentanoyl-n- (2'-(1h-tetrazol-5-yl-)- biphenyl-4-yl methyl) amine (valsartan)
NO20040860L (en) Pharmaceutical composition including lumiracoxib
NO20042563L (en) Composition composition containing acid-unstable physiologically active compounds and methods of preparation thereof
AU2003270149A1 (en) Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same
WO2003047517A3 (en) Novel-n-[4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
AU2002254631A1 (en) Enantiomers of n-((2'-(((4,5-dimethyl-3-isoxazolyl) amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-n,3,3-trimethylbutanamide
NO20034524L (en) 5-membered heterocycles, preparation and use thereof as MAO inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as drugs.
WO2007010235A8 (en) Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide
DK1532141T3 (en) 2-Pyrrolidin-2-yl [1,3,4] oxadiazole derivatives and their use as antidepressants
AU2003235814A1 (en) Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide